They bring a nice loss as a dowry… They finally found a more efficient way… Rubius has recently generated new non-human primate data with the next generation cell conjugation RED PLATFORM, demonstrating longer circulation time than observed with the first generation platform and pronounced pharmacodynamic effects as shown by increased levels of interferon gamma, a cytokine critical to both innate and adaptive immunity. In parallel, the Company has advanced a next generation Red Cell Therapeutic, RTX-250, an antigen-specific therapy that is designed to activate dendritic cells. … will it be true? is there any value?
0.15/0.10? i don't have many and i kept something to load at those levels! but maybe I'll stop, except that... https://fintel.io/so/us/ruby why do they still keep all this?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.